Ann Arbor, MI, United States of America

Lycera Corporation


Patents = 36

Forward Citations = 220


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


46 inventors (with patents filed for the assignee):


Lycera Corporation is a biopharmaceutical company focused on developing innovative oral immune modulators for the treatment of autoimmune diseases and cancer. The company's proprietary platform enables the discovery of small molecules that target immune cells to restore and maintain normal immune function. Lycera's goal is to create safe and effective therapies that provide substantial benefits to patients in need.
This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com
Loading…